ARDIÇLI, Ö. Et Al. 2022. A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd). ALLERGY , vol.77, no.8 , 2565-2567.

ARDIÇLI, Ö., Azkur, A. K., & Azkur, D., (2022). A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd). ALLERGY , vol.77, no.8, 2565-2567.

ARDIÇLI, ÖZGE, Ahmet Kursat Azkur, And Dilek Azkur. "A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)," ALLERGY , vol.77, no.8, 2565-2567, 2022

ARDIÇLI, ÖZGE Et Al. "A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)." ALLERGY , vol.77, no.8, pp.2565-2567, 2022

ARDIÇLI, Ö. Azkur, A. K. And Azkur, D. (2022) . "A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)." ALLERGY , vol.77, no.8, pp.2565-2567.

@article{article, author={ÖZGE ARDIÇLI Et Al. }, title={A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)}, journal={ALLERGY}, year=2022, pages={2565-2567} }